Aerocrine AB is a medical products company focused on improved management and care of patients with inflammatory airway diseases such as Asthma. Within this sector, Aerocrine is the world leader. Aerocrine markets NIOX MINO® and NIOX VERO®, , which enables fast and reliable point-of-care measurement of airway inflammation. These products play a critical role in more effective diagnosis, treatment and follow-up of patients affected with inflammatory airway diseases. Aerocrine is based in Sweden with subsidiaries in the US, Germany, Switzerland and the UK. In June 2015, Aerocrine became part of Circassia Pharmaceuticals plc. For more information please visit www.aerocrine.com and www.niox.com.
| Website | http://www.niox.com |
| Revenue | $6.4 million |
| Employees | 29 (9 on RocketReach) |
| Founded | 1997 |
| Phone | +46 8 629 07 80 |
| Fax | (662) 587-0255 |
| Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Medical devices, Manufacturing |
| Web Rank | 3 Million |
| Keywords | Lung Function Testing, Respiratory Diagnostics, Asthma Treatment, Point-Of-Care Diagnostics, Pulmonary Diagnostics, Medical Diagnostic Equipment, Medical Device Technology |
| Competitors | Circassia DE, Allergopharma J. Ganzer KG Pharmazeutische Erzeugnisse, Thermo Fisher Scientific, Novartis, Mylan Belgium, GSK, Merck Group, Cleveland Clinic, Boehringer Ingelheim, Pfizer +47 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Aerocrine employee's phone or email?
The Aerocrine annual revenue was $6.4 million in 2026.
9 people are employed at Aerocrine.
The NAICS codes for Aerocrine are [339, 33].
The SIC codes for Aerocrine are [38, 384].